Related Experiment Videos
Equine muscular dystrophy with myotonia
P Montagna1, R Liguori, L Monari
1Institute of Clinical Neurology, University of Bologna Medical School, Via U. Foscolo 7, 40123, Bologna, Italy. pmontagn@neuro.unibo.it
Summary
This study details a horse with equine muscular dystrophy and myotonia, exhibiting muscle weakness and delayed relaxation. Pharmacological treatments showed differences compared to human myotonic dystrophy.
Area of Science:
- Veterinary Neurology
- Equine Medicine
- Muscle Physiology
Background:
- Equine muscular dystrophy is a rare condition affecting horses.
- Myotonia, characterized by delayed muscle relaxation, can occur secondary to dystrophic changes.
Purpose of the Study:
- To document a clinical case of equine muscular dystrophy presenting with myotonia.
- To investigate the clinical, electrophysiological, and pathological features of this condition.
- To explore potential therapeutic responses.
Main Methods:
- Clinical examination of a 5-year-old horse with hindlimb muscle hypertrophy and delayed relaxation.
- Electromyography (EMG) to assess muscle electrical activity.
- Gluteal muscle biopsy for histopathological analysis.
- Pharmacological testing with apamin and lidocaine.
Main Results:
- The horse exhibited action and percussion myotonia, muscle weakness, and myopathic features on EMG.
- Histopathology revealed adipose and connective tissue infiltration, variable fiber size, and characteristic fiber changes.
- Apamin, a potassium channel blocker, was ineffective, while lidocaine successfully reduced myotonic discharges.
Conclusions:
- The equine case presented with myotonia associated with dystrophic changes, similar to human myotonic dystrophy.
- Pharmacological responses differed from human myotonic dystrophy, suggesting distinct pathophysiological mechanisms or channelopathies.